ERBB2 and breast carcinoma: As a previous study by Nagpal and colleagues also confirmed that ferroptosis was induced by neratinib in HER2-postive human (SKBR3) and mouse (TBCP1) breast cancer cell lines [14], we hypothesised that neratinib-induced ferroptosis might extend beyond the context of breast cancer.